PHILADELPHIA--(BUSINESS WIRE)-- Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, announced today that it has received approval from the U.S. Food and Drug Administration ...
The study met the primary endpoint, demonstrating a complete response of 89% in the ondansetron extended release injection arm vs 82% in the standard ondansetron injection arm. Topline data were ...
BD Simplist Prefilled Ondansetron Injection Approved The FDA has approved BD Rx's Ondansetron Injection, the third drug from the new BD Simplist line of ready-to-administer prefilled generic ...
SAN FRANCISCO (MarketWatch) -- Teva Pharmaceutical Industries Ltd. said Wednesday the Food and Drug Administration has granted final approval for Ondansetron injection, the generic version of ...
ISSUE: Hospira, Inc. announced it initiated a voluntary nationwide recall of one lot of Metoclopramide Injection, USP, 10 mg/2 mL (5 mg/mL)and two lots of Ondansetron Injection, USP, 4 mg/2 mL, (2 ...
Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections RAICHUR, India, Nov. 11, ...
April 7, 2005 — The U.S. Food and Drug Administration (FDA) has approved an intravenous formulation of esomeprazole magnesium for the short-term treatment of gastroesophageal reflux disease in ...
The Minister of Health should reveal all details pertaining to the controversial Ondansetron injections including the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback